IBDEI3FY ; ; 19-NOV-2015
;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,57892,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,57892,1,2,0)
;;=2^92228
;;^UTILITY(U,$J,358.3,57892,1,3,0)
;;=3^REMOTE IMAGING-RETINAL MGMT
;;^UTILITY(U,$J,358.3,57893,0)
;;=92250^^271^2899^1^^^^1
;;^UTILITY(U,$J,358.3,57893,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,57893,1,2,0)
;;=2^92250
;;^UTILITY(U,$J,358.3,57893,1,3,0)
;;=3^FUNDUS PHOTO W/ INTERP & RPT
;;^UTILITY(U,$J,358.3,57894,0)
;;=T1014^^271^2899^6^^^^1
;;^UTILITY(U,$J,358.3,57894,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,57894,1,2,0)
;;=2^T1014
;;^UTILITY(U,$J,358.3,57894,1,3,0)
;;=3^TELEHEALTH TRANSMIT, PER MIN
;;^UTILITY(U,$J,358.3,57895,0)
;;=3072F^^271^2899^2^^^^1
;;^UTILITY(U,$J,358.3,57895,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,57895,1,2,0)
;;=2^3072F
;;^UTILITY(U,$J,358.3,57895,1,3,0)
;;=3^LOW RISK FOR RETINOPATHY
;;^UTILITY(U,$J,358.3,57896,0)
;;=B02.33^^272^2900^161
;;^UTILITY(U,$J,358.3,57896,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57896,1,3,0)
;;=3^Zoster Keratitis
;;^UTILITY(U,$J,358.3,57896,1,4,0)
;;=4^B02.33
;;^UTILITY(U,$J,358.3,57896,2)
;;=^5000496
;;^UTILITY(U,$J,358.3,57897,0)
;;=B02.32^^272^2900^160
;;^UTILITY(U,$J,358.3,57897,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57897,1,3,0)
;;=3^Zoster Iridocyclitis
;;^UTILITY(U,$J,358.3,57897,1,4,0)
;;=4^B02.32
;;^UTILITY(U,$J,358.3,57897,2)
;;=^5000495
;;^UTILITY(U,$J,358.3,57898,0)
;;=B00.52^^272^2900^82
;;^UTILITY(U,$J,358.3,57898,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57898,1,3,0)
;;=3^Herpesviral Keratitis
;;^UTILITY(U,$J,358.3,57898,1,4,0)
;;=4^B00.52
;;^UTILITY(U,$J,358.3,57898,2)
;;=^5000474
;;^UTILITY(U,$J,358.3,57899,0)
;;=B00.51^^272^2900^81
;;^UTILITY(U,$J,358.3,57899,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57899,1,3,0)
;;=3^Herpesviral Iridocyclitis
;;^UTILITY(U,$J,358.3,57899,1,4,0)
;;=4^B00.51
;;^UTILITY(U,$J,358.3,57899,2)
;;=^5000473
;;^UTILITY(U,$J,358.3,57900,0)
;;=B30.8^^272^2900^47
;;^UTILITY(U,$J,358.3,57900,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57900,1,3,0)
;;=3^Conjunctivitis,Viral NEC
;;^UTILITY(U,$J,358.3,57900,1,4,0)
;;=4^B30.8
;;^UTILITY(U,$J,358.3,57900,2)
;;=^88239
;;^UTILITY(U,$J,358.3,57901,0)
;;=C69.41^^272^2900^113
;;^UTILITY(U,$J,358.3,57901,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57901,1,3,0)
;;=3^Malig Neop of Right Ciliary Body
;;^UTILITY(U,$J,358.3,57901,1,4,0)
;;=4^C69.41
;;^UTILITY(U,$J,358.3,57901,2)
;;=^5001279
;;^UTILITY(U,$J,358.3,57902,0)
;;=C69.42^^272^2900^111
;;^UTILITY(U,$J,358.3,57902,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57902,1,3,0)
;;=3^Malig Neop of Left Ciliary Body
;;^UTILITY(U,$J,358.3,57902,1,4,0)
;;=4^C69.42
;;^UTILITY(U,$J,358.3,57902,2)
;;=^5001280
;;^UTILITY(U,$J,358.3,57903,0)
;;=C69.01^^272^2900^114
;;^UTILITY(U,$J,358.3,57903,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57903,1,3,0)
;;=3^Malig Neop of Right Conjunctiva
;;^UTILITY(U,$J,358.3,57903,1,4,0)
;;=4^C69.01
;;^UTILITY(U,$J,358.3,57903,2)
;;=^5001267
;;^UTILITY(U,$J,358.3,57904,0)
;;=C69.02^^272^2900^112
;;^UTILITY(U,$J,358.3,57904,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57904,1,3,0)
;;=3^Malig Neop of Left Conjunctiva
;;^UTILITY(U,$J,358.3,57904,1,4,0)
;;=4^C69.02
;;^UTILITY(U,$J,358.3,57904,2)
;;=^5001268
;;^UTILITY(U,$J,358.3,57905,0)
;;=D31.41^^272^2900^17
;;^UTILITY(U,$J,358.3,57905,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57905,1,3,0)
;;=3^Benign Neop of Right Ciliary Body
;;^UTILITY(U,$J,358.3,57905,1,4,0)
;;=4^D31.41
;;^UTILITY(U,$J,358.3,57905,2)
;;=^5002124
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3FY 3956 printed Dec 13, 2024@02:48:01 Page 2
IBDEI3FY ; ; 19-NOV-2015
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,57892,1,0)
+2 ;;=^358.31IA^3^2
+3 ;;^UTILITY(U,$J,358.3,57892,1,2,0)
+4 ;;=2^92228
+5 ;;^UTILITY(U,$J,358.3,57892,1,3,0)
+6 ;;=3^REMOTE IMAGING-RETINAL MGMT
+7 ;;^UTILITY(U,$J,358.3,57893,0)
+8 ;;=92250^^271^2899^1^^^^1
+9 ;;^UTILITY(U,$J,358.3,57893,1,0)
+10 ;;=^358.31IA^3^2
+11 ;;^UTILITY(U,$J,358.3,57893,1,2,0)
+12 ;;=2^92250
+13 ;;^UTILITY(U,$J,358.3,57893,1,3,0)
+14 ;;=3^FUNDUS PHOTO W/ INTERP & RPT
+15 ;;^UTILITY(U,$J,358.3,57894,0)
+16 ;;=T1014^^271^2899^6^^^^1
+17 ;;^UTILITY(U,$J,358.3,57894,1,0)
+18 ;;=^358.31IA^3^2
+19 ;;^UTILITY(U,$J,358.3,57894,1,2,0)
+20 ;;=2^T1014
+21 ;;^UTILITY(U,$J,358.3,57894,1,3,0)
+22 ;;=3^TELEHEALTH TRANSMIT, PER MIN
+23 ;;^UTILITY(U,$J,358.3,57895,0)
+24 ;;=3072F^^271^2899^2^^^^1
+25 ;;^UTILITY(U,$J,358.3,57895,1,0)
+26 ;;=^358.31IA^3^2
+27 ;;^UTILITY(U,$J,358.3,57895,1,2,0)
+28 ;;=2^3072F
+29 ;;^UTILITY(U,$J,358.3,57895,1,3,0)
+30 ;;=3^LOW RISK FOR RETINOPATHY
+31 ;;^UTILITY(U,$J,358.3,57896,0)
+32 ;;=B02.33^^272^2900^161
+33 ;;^UTILITY(U,$J,358.3,57896,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,57896,1,3,0)
+36 ;;=3^Zoster Keratitis
+37 ;;^UTILITY(U,$J,358.3,57896,1,4,0)
+38 ;;=4^B02.33
+39 ;;^UTILITY(U,$J,358.3,57896,2)
+40 ;;=^5000496
+41 ;;^UTILITY(U,$J,358.3,57897,0)
+42 ;;=B02.32^^272^2900^160
+43 ;;^UTILITY(U,$J,358.3,57897,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,57897,1,3,0)
+46 ;;=3^Zoster Iridocyclitis
+47 ;;^UTILITY(U,$J,358.3,57897,1,4,0)
+48 ;;=4^B02.32
+49 ;;^UTILITY(U,$J,358.3,57897,2)
+50 ;;=^5000495
+51 ;;^UTILITY(U,$J,358.3,57898,0)
+52 ;;=B00.52^^272^2900^82
+53 ;;^UTILITY(U,$J,358.3,57898,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,57898,1,3,0)
+56 ;;=3^Herpesviral Keratitis
+57 ;;^UTILITY(U,$J,358.3,57898,1,4,0)
+58 ;;=4^B00.52
+59 ;;^UTILITY(U,$J,358.3,57898,2)
+60 ;;=^5000474
+61 ;;^UTILITY(U,$J,358.3,57899,0)
+62 ;;=B00.51^^272^2900^81
+63 ;;^UTILITY(U,$J,358.3,57899,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,57899,1,3,0)
+66 ;;=3^Herpesviral Iridocyclitis
+67 ;;^UTILITY(U,$J,358.3,57899,1,4,0)
+68 ;;=4^B00.51
+69 ;;^UTILITY(U,$J,358.3,57899,2)
+70 ;;=^5000473
+71 ;;^UTILITY(U,$J,358.3,57900,0)
+72 ;;=B30.8^^272^2900^47
+73 ;;^UTILITY(U,$J,358.3,57900,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,57900,1,3,0)
+76 ;;=3^Conjunctivitis,Viral NEC
+77 ;;^UTILITY(U,$J,358.3,57900,1,4,0)
+78 ;;=4^B30.8
+79 ;;^UTILITY(U,$J,358.3,57900,2)
+80 ;;=^88239
+81 ;;^UTILITY(U,$J,358.3,57901,0)
+82 ;;=C69.41^^272^2900^113
+83 ;;^UTILITY(U,$J,358.3,57901,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,57901,1,3,0)
+86 ;;=3^Malig Neop of Right Ciliary Body
+87 ;;^UTILITY(U,$J,358.3,57901,1,4,0)
+88 ;;=4^C69.41
+89 ;;^UTILITY(U,$J,358.3,57901,2)
+90 ;;=^5001279
+91 ;;^UTILITY(U,$J,358.3,57902,0)
+92 ;;=C69.42^^272^2900^111
+93 ;;^UTILITY(U,$J,358.3,57902,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,57902,1,3,0)
+96 ;;=3^Malig Neop of Left Ciliary Body
+97 ;;^UTILITY(U,$J,358.3,57902,1,4,0)
+98 ;;=4^C69.42
+99 ;;^UTILITY(U,$J,358.3,57902,2)
+100 ;;=^5001280
+101 ;;^UTILITY(U,$J,358.3,57903,0)
+102 ;;=C69.01^^272^2900^114
+103 ;;^UTILITY(U,$J,358.3,57903,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,57903,1,3,0)
+106 ;;=3^Malig Neop of Right Conjunctiva
+107 ;;^UTILITY(U,$J,358.3,57903,1,4,0)
+108 ;;=4^C69.01
+109 ;;^UTILITY(U,$J,358.3,57903,2)
+110 ;;=^5001267
+111 ;;^UTILITY(U,$J,358.3,57904,0)
+112 ;;=C69.02^^272^2900^112
+113 ;;^UTILITY(U,$J,358.3,57904,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,57904,1,3,0)
+116 ;;=3^Malig Neop of Left Conjunctiva
+117 ;;^UTILITY(U,$J,358.3,57904,1,4,0)
+118 ;;=4^C69.02
+119 ;;^UTILITY(U,$J,358.3,57904,2)
+120 ;;=^5001268
+121 ;;^UTILITY(U,$J,358.3,57905,0)
+122 ;;=D31.41^^272^2900^17
+123 ;;^UTILITY(U,$J,358.3,57905,1,0)
+124 ;;=^358.31IA^4^2
+125 ;;^UTILITY(U,$J,358.3,57905,1,3,0)
+126 ;;=3^Benign Neop of Right Ciliary Body
+127 ;;^UTILITY(U,$J,358.3,57905,1,4,0)
+128 ;;=4^D31.41
+129 ;;^UTILITY(U,$J,358.3,57905,2)
+130 ;;=^5002124
